Showing results (1-10 of 116) with videos related to
Sort By:
Pageof 12
Journal of Biomolecular Screening|April 23, 2013
Development of a colorimetric and a fluorescence phosphatase-inhibitor assay suitable for drug discovery approachesHannieh Sotoud, Philip Gribbon, Bernhard Ellinger, et al.Expert Opinion on Drug Discovery|July 25, 2012
Exemplification of the challenges associated with utilising fluorescence intensity based assays in discoverySheraz Gul, Philip GribbonMarine Drugs|March 24, 2017
Establishing the Secondary Metabolite Profile of the Marine Fungus: Tolypocladium geodes sp. MF458 and Subsequent Optimisation of Bioactive Secondary Metabolite ProductionBethlehem Kebede, Stephen K Wrigley, Anjali Prashar, et al.Drug Discovery Today|December 24, 2003
Fluorescence readouts in HTS: no gain without pain?Philip Gribbon, Andreas SewingScientific Data|February 27, 2021
A SARS-CoV-2 cytopathicity dataset generated by high-content screening of a large drug repurposing collectionBernhard Ellinger, Denisa Bojkova, Andrea Zaliani, et al.Journal of Biomolecular Screening|August 12, 2011
A bioluminogenic HDAC activity assay: validation and screeningFrancoise Halley, Jeanette Reinshagen, Bernhard Ellinger, et al.Assay and Drug Development Technologies|April 17, 2014
A phenotypic screening approach to identify anticancer compounds derived from marine fungiBernhard Ellinger, Johanna Silber, Anjali Prashar, et al.Drugs|March 7, 2022
Drug Repurposing to Target Neuroinflammation and Sensory Neuron-Dependent PainMarco Sisignano, Philip Gribbon, Gerd GeisslingerACS Omega|August 28, 2023
Pharmacophore-Based Machine Learning Model To Predict Ligand Selectivity for E3 Ligase BindersReagon Karki, Yojana Gadiya, Philip Gribbon, et al.Bioinformatics Advances|May 15, 2023
Mpox Knowledge Graph: a comprehensive representation embedding chemical entities and associated biology of MpoxReagon Karki, Yojana Gadiya, Andrea Zaliani, et al.Pageof 12